ORTHOPEDIATRICS CORP insider Jennifer N. Pritzker sold 302,369 shares at $21.01 per share on 2026-09-10. The transaction left her with 6,201,764 shares and represented about 4.6% of her prior holding, giving investors the disclosed scale of the sale and her remaining position.
Key Highlights
- The transaction used code S, which classifies it as an open-market sale.
- Pritzker held 6,201,764 shares after the transaction.
- The sale represented about 4.6% of her prior shares holding.
ORTHOPEDIATRICS CORP (NASDAQ: KIDS) insider Jennifer N. Pritzker sold 302,369 shares at $21.01 per share on 10 September 2026.
Pritzker’s Remaining ORTHOPEDIATRICS Position
Pritzker held 6,201,764 ORTHOPEDIATRICS CORP shares after the transaction. The reported trade involved shares of the company at a price of $21.01 per share.
Sale Covered 4.6% of Prior Holding
The transaction represented about 4.6% of Pritzker’s prior shares holding. The disclosed percentage measures the sold position against her holdings before the transaction. Her post-transaction ownership was 6,201,764 shares.
FAQs
Q: How many ORTHOPEDIATRICS shares did Jennifer Pritzker sell?
A: The filing reports that Jennifer N. Pritzker sold 302,369 ORTHOPEDIATRICS CORP shares. The shares were sold at $21.01 per share on 10 September 2026 in an open-market transaction.
Q: What is Pritzker’s remaining ORTHOPEDIATRICS holding?
A: After the transaction, Pritzker owned 6,201,764 ORTHOPEDIATRICS CORP shares. The sold amount represented about 4.6% of her prior shares holding.
Q: What does code S mean in the ORTHOPEDIATRICS insider transaction?
A: In this filing, code S identifies an open-market sale. It records Pritzker’s sale of 302,369 shares at $21.01 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.